Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
Stephen D. Wiviott(Brigham and Women's Hospital), Eugene Braunwald(Mass General Brigham), Gilles Montalescot(Maastricht University Medical Centre), Dominick J. Angiolillo(University of Florida), Hanoch Hod(University of Nottingham), Alan D. Michelson(Harvard University), Andrew L. Frelinger(University of Nottingham), Dietmar Trenk(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Michelle L. O’Donoghue(Brigham and Women's Hospital), Sabina A. Murphy(Brigham and Women's Hospital), Franz‐Josef Neumann(University of Freiburg), Carolyn H. McCabe(Brigham and Women's Hospital), Richard Cairns(University of Nottingham), Debra L. Miller(University of Nottingham), Joseph A. Jakubowski(University of Nottingham), Elliott M. Antman(Brigham and Women's Hospital)
Cited by 877
Related Papers
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2013|5.1k
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
|New England Journal of Medicine|2015|2k